Exploring the association between mild behavioral impairment and plasma p‐tau217: Implications for early detection of Alzheimer's disease
Abstract INTRODUCTION Mild behavioral impairment (MBI), marked by late‐onset persistent neuropsychiatric symptoms (NPS), may signal early dementia risk. While MBI is linked to previously established amyloid‐beta (Aβ) and tau biomarkers, its association with plasma p‐tau217, a promising blood‐based b...
Saved in:
| Main Authors: | Maryam Ghahremani, Rebeca Leon, Eric E. Smith, Zahinoor Ismail |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/dad2.70119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The two cut‐offs approach for plasma p‐tau217 in detecting Alzheimer's disease in subjective cognitive decline and mild cognitive impairment
by: Giulia Giacomucci, et al.
Published: (2025-04-01) -
Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217
by: Giulia Musso, et al.
Published: (2025-08-01) -
Identification of late-stage tau accumulation using plasma phospho-tau217Research in context
by: Marcel S. Woo, et al.
Published: (2024-11-01) -
A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies
by: Giavanna Paterno, et al.
Published: (2025-06-01) -
Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort
by: Neetesh Pandey, et al.
Published: (2025-01-01)